Demodicosis is a skin disease caused by the overgrowth of tiny Demodex mites that naturally live in human hair follicles and oil glands. Nearly every adult carries these mites without any symptoms at all, but when populations spike, the result can be persistent facial redness, rough or flaky skin, eyelid irritation, and sometimes unusual pigmentation. What makes the condition tricky is that the line between harmless passenger and pathological infestation depends on your immune system, your age, and factors that are still being worked out by researchers.
The Mites Behind the Disease
Two species of Demodex mite are responsible. Demodex folliculorum lives inside hair follicles, while Demodex brevis prefers the deeper sebaceous (oil) glands. Both are microscopic, roughly a third of a millimeter long, and they cluster on the face, especially the cheeks, chin, nose, and eyelids.1PubMed Central. Significance of Demodex folliculorum and Demodex brevis in Pathogenesis of Dermatological Diseases-Current State of Knowledge They feed on sebum and dead skin cells, spend their entire life cycle on the host, and are passed from person to person through close skin contact, typically during infancy from a parent’s face.
How common are they? Enormously. Visual inspection finds them on about a third of children and young adults, about half of middle-aged adults, and roughly two-thirds of people over sixty.2PubMed Central. Demodex: The worst enemies are the ones that used to be friends A global meta-analysis put the prevalence in older adults at around 59%.3Acta Tropica. Global prevalence of Human Demodex Mite: A systematic review and meta-analysis But even those numbers probably undercount the real picture. When researchers used DNA-based detection instead of looking for whole mites under a microscope, they found Demodex genetic material on every single adult tested.4PLOS ONE. Ubiquity and Diversity of Human-Associated Demodex Mites In practical terms, Demodex mites are a near-universal feature of adult human skin. The question is not whether you carry them, but whether they are causing trouble.
How a Harmless Hitchhiker Becomes a Problem
Under normal circumstances, your immune system keeps Demodex populations in check through a specific arm of immunity involving cells called group 2 innate lymphoid cells. These cells produce a signaling molecule, IL-13, that slows down the growth cycle of hair follicles and limits the environment the mites thrive in. When that immune checkpoint works, you can carry a modest population of mites without any symptoms at all. When it fails, mite numbers climb, follicles become inflamed, and the skin’s barrier begins to break down.5PubMed Central. Innate type 2 immunity controls hair follicle commensalism by Demodex mites
Mice engineered to lack this type 2 immune signaling developed dramatic mite overgrowth, with massive inflammatory cell infiltration and eventual destruction of hair follicles. Interestingly, mice lacking adaptive immune cells (the B and T cells involved in learned immunity) still managed to keep mites under control as long as the innate type 2 pathway was intact.6Immunity. Type 2 immunity and innate lymphoid cells protect the skin against Demodex mites That finding reshaped how researchers think about demodicosis. The key gatekeeper is not your overall immune strength but a specific, innate immune pathway in the skin.
There is also a bacterial angle. A bacterium called Bacillus oleronius has been isolated from inside Demodex mites, and rosacea patients show immune reactions to its proteins. Researchers suspect that when mite populations grow large enough, the bacterial load they carry triggers additional inflammation on top of the mechanical damage the mites cause.7PubMed. Correlation between serum reactivity to Demodex-associated Bacillus oleronius proteins, and altered sebum levels and Demodex populations in erythematotelangiectatic rosacea patients
Who Is at Higher Risk
Age is the single most consistent risk factor. Mite density rises steadily through life, and clinical demodicosis is more common in older adults. But immune suppression of any kind can tip the balance much earlier. Organ transplant recipients on immunosuppressive drugs, people with HIV, and patients on long-term systemic corticosteroids or chemotherapy all face elevated risk.8PubMed Central. Demodicosis among immunocompromised patients: a review Because demodicosis on an immunosuppressed patient can look like a drug reaction or a different infection entirely, it is likely underdiagnosed in that population.
Sebum production matters too. Oilier skin supports larger mite colonies, and facial areas with the highest sebaceous gland density, like the nose and nasolabial folds, are hit hardest. Conversely, some studies have found that rosacea patients with elevated mite counts actually have reduced sebum levels, suggesting that at a certain point the mites are consuming more oil than the glands can produce.9PubMed. Correlation between serum reactivity to Demodex-associated Bacillus oleronius proteins, and altered sebum levels and Demodex populations in erythematotelangiectatic rosacea patients
What Demodicosis Looks Like on the Skin
The condition wears several faces, and this is one reason it often goes unrecognized.
The classic presentation is pityriasis folliculorum, a diffuse facial roughness described as a “nutmeg grater” texture when felt with the fingertips. The skin appears dry and flushed, with fine white scales plugging individual follicles that are easiest to see under angled lighting with magnification.10JAMA Dermatology. Demodectic Eruptions (Demodicidosis) in the Human: 30 Years’ Experience with 2 Commonly Unrecognized Entities: Pityriasis Folliculorum (Demodex) and Acne Rosacea (Demodex Type) People with this form often think they have persistently dry or sensitive skin that does not respond to moisturizers, because the problem is not dryness at all but follicular plugging.
The rosacea connection is well established. A meta-analysis found that mite densities were significantly higher in both the redness-dominated and the bumpy-pustular subtypes of rosacea compared with healthy controls.11PubMed. Role of Demodex mite infestation in rosacea: A systematic review and meta-analysis This does not mean every rosacea case is driven by Demodex, but it does mean that mite density is worth investigating in anyone with persistent facial redness, especially if standard rosacea treatments are not helping.
A less well-known variant is pigmented demodicidosis, where the main symptom is a dusky, brownish-gray discoloration on the face rather than obvious redness. In one case series, most patients presented with this pigmentation as their primary concern, with background redness in only about a third of cases and skin roughness in about a quarter. Under dermoscopy, the giveaway was white gelatinous plugs protruding from follicles, along with a characteristic reticulated pattern of pigmentation around them.12PubMed. Pigmented demodicidosis – an under-recognized cause of facial hyperpigmentation This variant is particularly easy to misdiagnose as melasma or post-inflammatory hyperpigmentation, conditions that are treated very differently.
When It Affects the Eyes
Demodex blepharitis, inflammation of the eyelid margins caused by mites living in eyelash follicles, deserves its own discussion because it produces a distinctive set of symptoms and has its own treatment landscape. The hallmark sign is cylindrical dandruff: waxy, tube-like collarettes that wrap around the base of individual lashes. These are essentially casts of dead mite bodies, eggs, and debris cemented to the lash shaft.13PubMed Central. Demodex and the eye – A review In symptomatic patients with cylindrical dandruff, mite counts per lash are typically elevated, with many patients harboring three to eight mites per follicle.14PubMed Central. Blepharitis: Always Remember Demodex
Symptoms include chronic itching or burning of the eyelid margins, gritty or sandy sensation, redness along the lash line, and sometimes blurred vision from secondary tear-film instability. Eyelid demodicosis frequently coexists with facial skin disease. People with more severe eyelid infestations tend to have higher mite densities on the forehead and more pronounced facial erythema, suggesting the two are different expressions of the same underlying overgrowth.15PubMed Central. Safety and Effectiveness of Lotilaner Ophthalmic Solution (0.25%) in Treating Demodex Blepharitis: Pooled Analysis of Two Pivotal Trials – Section: Results
How Demodicosis Is Diagnosed
The traditional approach is a standardized skin surface biopsy: a small square of adhesive is pressed to the skin, peeled off, and examined under a microscope. A count of five or more mites per square centimeter is the widely used threshold for pathological infestation. A simpler version for the eyelids involves pulling a few lashes and looking for mites clinging to the roots.
A newer tool is reflectance confocal microscopy, which can visualize mites living inside follicles in real time without removing any tissue. Studies have found it superior to traditional surface biopsy for detecting Demodex because it can image mites sitting deeper in the follicle that a surface scraping would miss.16PubMed. Reflectance confocal microscopy vs. standardized skin surface biopsy for measuring the density of Demodex mites It also allows clinicians to monitor mite counts over the course of treatment without repeated biopsies.17PubMed. Reflectance confocal microscopy for monitoring the density of Demodex mites in patients with rosacea before and after treatment The downside is that the equipment is expensive and available mostly in academic dermatology centers, so most diagnoses in everyday practice still rely on clinical suspicion and traditional scraping.
In the eyes, an experienced clinician can often make the diagnosis at the slit lamp by spotting cylindrical dandruff. Confirmation comes from pulling a few representative lashes and counting the mites under magnification.
Treatment for Skin Demodicosis
Topical ivermectin cream at 1% concentration is the most studied treatment for skin demodicosis and has become the workhorse therapy. A systematic review and meta-analysis of studies using daily application found an average reduction of about 70 mites per square centimeter, with roughly 80% of patients dropping below the pathological threshold after a 16-week course. The effect persisted for up to 12 weeks after stopping treatment, and side effects were limited to mild, localized skin reactions with no systemic toxicity.18PubMed Central. Efficacy of topical Ivermectin in controlling human Demodex infestation: Evidence from systematic review and meta-analysis
Oral ivermectin is another option, particularly for patients with higher mite burdens or widespread disease. In one trial, three-quarters of patients achieved clinical remission with oral treatment. Patients who started with lower mite densities reached remission in about four weeks, while those with heavier infestations took closer to eight weeks.19PubMed Central. Evaluating the Efficacy of Oral Ivermectin on Clinical Symptoms and Demodex Densities in Patients with Demodicosis Combining oral ivermectin with metronidazole may improve outcomes further. In a head-to-head comparison, the combination achieved complete remission in about 72% of patients, compared with 45% on oral ivermectin alone.20International Journal of Infectious Diseases. Evaluation of the efficacy of oral ivermectin in comparison with ivermectin–metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum
A practical point: because Demodex eggs take about two weeks to hatch, a single short course of treatment often fails. The mites you kill today may have already laid eggs that will repopulate the follicle after treatment stops. Courses of at least 12 to 16 weeks, or pulsed regimens timed to the mite life cycle, tend to produce more durable results.
Treatment for Demodex Blepharitis
Eye-area demodicosis has historically been harder to treat because many antiparasitic agents are too irritating for the delicate eyelid margins. Tea tree oil and its active component terpinen-4-ol have been the traditional go-to, applied as lid scrubs or ointments. Terpinen-4-ol delivered in a cyclic pattern that matches the mite hatching cycle has shown effectiveness in reducing adult and emerging mites.21PubMed. Efficacy of cyclic therapy with terpinen-4-ol in Demodex blepharitis: Is treatment possible by considering Demodex’s life cycle? However, the evidence base for tea tree oil treatments remains limited. A Cochrane review found the certainty of evidence too low to draw firm conclusions about its benefits compared to other approaches.22PubMed Central. Tea tree oil for Demodex blepharitis
The landscape shifted in 2023 with the FDA approval of lotilaner ophthalmic solution, the first prescription eye drop specifically designed for Demodex blepharitis. Lotilaner belongs to the isoxazoline class, the same drug family used in flea and tick treatments for pets. In pooled results from two pivotal trials, about 60% of treated patients achieved complete mite eradication by day 43, compared with 16% in the placebo group. Collarette clearance was similarly dramatic, with about half of treated patients reaching a cure compared to roughly 10% on placebo. Patients generally found the drops comfortable, and serious ocular side effects were not reported.23PubMed Central. Safety and Effectiveness of Lotilaner Ophthalmic Solution (0.25%) in Treating Demodex Blepharitis: Pooled Analysis of Two Pivotal Trials The approval was notable because it gave clinicians a well-tested, convenient treatment for a condition that previously relied on off-label lid scrubs and home remedies.
Demodicosis in Dogs and Cats
Demodex is not just a human problem. Dogs have their own species, Demodex canis, and the veterinary version of the disease is one of the most common reasons young dogs end up at a dermatologist. Canine demodicosis comes in two forms: localized, with a few small patches of hair loss, and generalized, with widespread skin involvement that can become severely inflamed and secondarily infected. There is a known genetic predisposition for the generalized juvenile form. Once mite numbers get high enough, dogs develop a pattern of immune exhaustion, with suppressed pro-inflammatory signals and elevated anti-inflammatory ones, which creates a vicious cycle that makes it harder for their immune system to clear the mites.24PubMed. Immunology and pathogenesis of canine demodicosis
Treatment in dogs has been revolutionized by isoxazoline drugs, the same class as the lotilaner eye drop mentioned above. Fluralaner, marketed as a chewable or spot-on flea and tick treatment, has proven remarkably effective against canine Demodex. A single oral dose reduced mite counts by about 99% within four weeks, and no mites could be found on any treated dog by eight weeks, with full hair regrowth.25PubMed Central. Efficacy of oral fluralaner for the treatment of canine generalized demodicosis: a molecular-level confirmation A larger European field study confirmed these results, with a single treatment eliminating mites in at least 98% of dogs whether they had juvenile-onset or adult-onset disease.26PubMed Central. A European field assessment of the efficacy of fluralaner (Bravecto®) chewable and spot-on formulations for treatment of dogs with generalized demodicosis Before these drugs arrived, treatment required months of miticide dips or daily oral medications with significant side effects, so the shift has been dramatic.
Cats can also develop demodicosis, though it is rarer. The feline species Demodex gatoi is unusual because, unlike most Demodex mites, it appears to be contagious between cats. In multi-cat households, intense itching, scaling, and patchy hair loss can spread from one cat to another. Diagnosis is made by finding characteristic short-bodied mites on skin scrapings or tape strips, and treatment has historically involved weekly dips or oral antiparasitic drugs over several months.27BioMed Central / Acta Veterinaria Scandinavica. Demodex gatoi-associated contagious pruritic dermatosis in cats–a report from six households in Finland
Demodex Mites as a Map of Human Migration
One of the more unexpected findings about Demodex has nothing to do with disease. Because the mites are transmitted almost exclusively through prolonged close contact, they track human family lineages with remarkable fidelity. A genetic study of D. folliculorum from people of different ancestries found that mite lineages clustered tightly by the geographic origin of their hosts. People of European descent carried one globally distributed lineage, while people of Asian, African, and Latin American ancestry hosted distinct lineages of their own. About 27% of the total genetic variation in these mites could be explained by the regional ancestry of the host alone.28PubMed Central. Global divergence of the human follicle mite Demodex folliculorum: Persistent associations between host ancestry and mite lineages The pattern is consistent with Demodex having accompanied humans out of Africa and diverging alongside us as populations separated across continents. Your face mites, in other words, carry a faint record of your ancestors’ migrations.